Cargando…
Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions
Background: The Academic Research Consortium have identified a set of major and minor risk factors in order to standardize the definition of a High Bleeding Risk (ACR-HBR). Aims: The aim of this study is to stratify the bleeding risk in patients included in the Cardio-Fribourg registry, according to...
Autores principales: | Doomun, Daphné, Doomun, Ianis, Schukraft, Sara, Arroyo, Diego, Cook, Selma, Huwyler, Tibor, Wenaweser, Peter, Stauffer, Jean-Christophe, Goy, Jean-Jacques, Togni, Mario, Puricel, Serban, Cook, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674503/ https://www.ncbi.nlm.nih.gov/pubmed/34926595 http://dx.doi.org/10.3389/fcvm.2021.620354 |
Ejemplares similares
-
Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study
por: Schukraft, Sara, et al.
Publicado: (2021) -
Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021) -
Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018) -
Is the folk medicine known as “The Secret” efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial
por: Ferry, Charlie, et al.
Publicado: (2022) -
Heart rate never lies: interventional cardiologist and Braude's quote revised
por: Cook, Stéphane, et al.
Publicado: (2016)